SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-090404
Filing Date
2021-07-08
Accepted
2021-07-08 21:53:54
Documents
2
Period of Report
2021-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2112802d9_form3.html 3  
1 FORM 3 tm2112802d9_form3.xml 3 3868
2 EXHIBIT 24 tm2112802d9_ex24.htm EX-24 8510
  Complete submission text file 0001104659-21-090404.txt   13766
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Issuer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109
Business Address
Fitzgerald Thomas A (Reporting) CIK: 0001854168 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40363 | Film No.: 211081543